S S Wagenaar
-
- Lung Cancer Treatments and Mutations 5
- Medical Imaging and Pathology Studies 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Inhalation and Respiratory Drug Delivery 3
- Metastasis and carcinoma case studies 3
- Oncology top 10%
- Lung Cancer Research Studies 5
- Cell Biology top 5%
- Cancer Research top 10%
-
- Neuroendocrine Tumor Research Advances 6
-
- Sarcoidosis and Beryllium Toxicity Research 3
- Co-authors
- Siegina G. EversSjoerd RodenhuisW. J. MooiJohannes L. BosPeter C. Van BodegomRobbert J.C. SlebosA. HUYSMANSG. Peter Vooijs
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
S S Wagenaar
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 108
- Pulmonary and Respiratory Medicine 501
- Oncology 376
- Cell Biology 225
- Cancer Research 175
- Molecular Biology 582
Countries citing papers authored by S S Wagenaar
This map shows the geographic impact of S S Wagenaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Wagenaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Wagenaar more than expected).
Fields of papers citing papers by S S Wagenaar
This network shows the impact of papers produced by S S Wagenaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Wagenaar. The network helps show where S S Wagenaar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S S Wagenaar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 37 | |
| 2 | 1999 | 26 | |
| 3 | 1997 | 14 | |
| 4 | 1995 | 13 | |
| 5 | 1995 | 6 | |
| 6 | 1994 | 20 | |
| 7 | Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. | 1993 | 119 |
| 8 | 1989 | 37 | |
| 9 | 1989 | 19 | |
| 10 | Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells. | 1989 | 19 |
| 11 | 1988 | 70 | |
| 12 | 1988 | 6 | |
| 13 | 1987 | 136 | |
| 14 | 1987 | 17 | |
| 15 | 1986 | 23 | |
| 16 | 1986 | 5 | |
| 17 | Small cell lung cancers contain intermediate filaments of the cytokeratin type. | 1985 | 18 |
| 18 | 1983 | 10 | |
| 19 | 1981 | 2 | |
| 20 | 1977 | 9 |
About S S Wagenaar
S S Wagenaar is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Physiology, Epidemiology and Internal Medicine, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Treatments and Mutations (5 papers), Medical Imaging and Pathology Studies (5 papers), Lung Cancer Research Studies (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Metastasis and carcinoma case studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (501 citations), Oncology (376 citations), Cell Biology (225 citations), Cancer Research (175 citations) and Molecular Biology (582 citations). S S Wagenaar has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Siegina G. Evers, Sjoerd Rodenhuis, W. J. Mooi, Johannes L. Bos, Peter C. Van Bodegom, Robbert J.C. Slebos, A. HUYSMANS, G. Peter Vooijs, F.C.S. Ramaekers and J. L. V. Broers. Their work appears in journals such as Histopathology, Lung Cancer, Respiration, Thorax and Journal of Thoracic and Cardiovascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.